Zydus and CMS partnership provides boost to commercialsation strategy for desidustat in China, says… EP News Bureau Feb 19, 2020 CMS will be responsible for the development, registration and commercialisation of desidustat in China, while Zydus will receive…
Zydus and CMS enter pact for Desidustat in Greater China Press Trust of India Jan 21, 2020 The agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease…
